Spyre Therapeutics Inc. (SYRE)
NASDAQ: SYRE
· Real-Time Price · USD
15.89
-0.09 (-0.56%)
At close: Oct 03, 2025, 3:59 PM
15.60
-1.83%
After-hours: Oct 03, 2025, 04:51 PM EDT
Spyre Therapeutics Revenue
Spyre Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending June 30, 2025, Spyre Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
0
Employees
73
Market Cap
959.77M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | -100.00% |
| Dec 31, 2023 | 886K | -61.96% |
| Dec 31, 2022 | 2.33M | -87.57% |
| Dec 31, 2021 | 18.74M | +Infinity% |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | -100.00% |
| Dec 31, 2018 | 3.89M | -25.30% |
| Dec 31, 2017 | 5.21M | +12.47% |
| Dec 31, 2016 | 4.63M | -23.94% |
| Dec 31, 2015 | 6.08M | +Infinity% |
| Dec 31, 2014 | 0 | n/a |